Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
Description
CONCLUSION: mRNA COVID-19 vaccines increase the risk of ITP relapse and can lead to a prolonged reduction in platelet count in a proportion of ITP patients, with no statistically significant difference between Comirnaty and Spikevax vaccines.
